Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C SIMON

Showing results (1411-1420 of 1,440) with videos related to

Pageof 144
Sort By:
NPJ Precision Oncology|May 29, 2023
Deep learning generates synthetic cancer histology for explainability and educationJames M Dolezal, Rachelle Wolk, Hanna M Hieromnimon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2016
Increasing Number of Passes Beyond 4 Does Not Increase Sensitivity of Detection of Pancreatic Malignancy by Endoscopic Ultrasound-Guided Fine-Needle AspirationMehdi Mohamadnejad, Daniel Mullady, Dayna S Early, et al.
Clinical and Experimental Immunology|June 22, 2013
A UK national audit of hereditary and acquired angioedemaS Jolles, P Williams, E Carne, et al.
Nature Communications|September 11, 2020
DNA methylation study of Huntington's disease and motor progression in patients and in animal modelsAke T Lu, Pritika Narayan, Matthew J Grant, et al.
Lancet (London, England)|February 6, 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trialDavid M Gershenson, Austin Miller, William E Brady, et al.
Frontiers in Oncology|October 22, 2025
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinomaJ-P Machiels, Y Tao, L Licitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2025
Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancerRobert L Hollis, Austin Miller, Heather A Lankes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian CarcinomaAilith Ewing, Alison Meynert, Michael Churchman, et al.
The Review of Scientific Instruments|March 3, 2012
The on-line charge breeding program at TRIUMF's Ion Trap For Atomic and Nuclear Science for precision mass measurementsM C Simon, J C Bale, U Chowdhury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
Pageof 144

Showing results (1411-1420 of 1,440) with videos related to

Sort By:
Pageof 144
NPJ Precision Oncology|May 29, 2023
Deep learning generates synthetic cancer histology for explainability and educationJames M Dolezal, Rachelle Wolk, Hanna M Hieromnimon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2016
Increasing Number of Passes Beyond 4 Does Not Increase Sensitivity of Detection of Pancreatic Malignancy by Endoscopic Ultrasound-Guided Fine-Needle AspirationMehdi Mohamadnejad, Daniel Mullady, Dayna S Early, et al.
Clinical and Experimental Immunology|June 22, 2013
A UK national audit of hereditary and acquired angioedemaS Jolles, P Williams, E Carne, et al.
Nature Communications|September 11, 2020
DNA methylation study of Huntington's disease and motor progression in patients and in animal modelsAke T Lu, Pritika Narayan, Matthew J Grant, et al.
Lancet (London, England)|February 6, 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trialDavid M Gershenson, Austin Miller, William E Brady, et al.
Frontiers in Oncology|October 22, 2025
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinomaJ-P Machiels, Y Tao, L Licitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2025
Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancerRobert L Hollis, Austin Miller, Heather A Lankes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian CarcinomaAilith Ewing, Alison Meynert, Michael Churchman, et al.
The Review of Scientific Instruments|March 3, 2012
The on-line charge breeding program at TRIUMF's Ion Trap For Atomic and Nuclear Science for precision mass measurementsM C Simon, J C Bale, U Chowdhury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
Pageof 144